REG - Genus - Director/PDMR Shareholding

GenusAnnouncement

28/02/2025 13:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250228:nRSb9334Ya&default-theme=true

RNS Number : 9334Y  Genus PLC  28 February 2025

28 February 2025

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that further to the vesting on 28 February 2025
of 44,933 nil-cost options granted on 2 May 2023 over ordinary shares pursuant
to Listing Rule 9.4.2R, as listed in table A below, Jorgen Kokke, Chief
Executive Officer, sold 19,967 ordinary shares in Genus on 28 February 2025 on
the London Stock Exchange to offset income tax and social security liabilities
due on the exercise of those vested options and retained the balance of 24,966
ordinary shares.

 

The below notifications, made in accordance with Article 19 of the Market
Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of
the European Union (Withdrawal) Act 2018, give further detail on the number of
nil-cost options exercised and ordinary shares sold on 28 February 2025.

 

For further information please contact:

 

Genus:

Cara Guedeney, Deputy Company
Secretary
Tel: +44 (0)1256 347100

 

 

 

Table A - Exercise of buy-out awards vesting on 28 February 2025

 1.                    Details of the person discharging managerial responsibilities / person closely
                       associated
 a.                    Name                                       Jorgen Kokke
 2.                    Reason for the notification
 a.                    Position/status                            Chief Executive
 b.                    Initial notification                       Initial notification

                       /Amendment
 3.                    Details of the issuer, emission allowance market participant, auction
                       platform, auctioneer or auction monitor
 a.                    Name                                       Genus plc
 b.                    LEI                                        54930022EOITNKSIGH56
 4.                    Details of the transaction(s): section to be repeated for (i) each type of
                       instrument; (ii) each type of transaction; (iii) each date; and (iv) each
                       place where transactions have been conducted
 a.                    Description of the                         Ordinary shares of 10p each

                       Financial instrument, type of instrument

                       Identification code

                                                                  GB0002074580
 b.                    Nature of the transaction                  Exercise of nil-cost options granted on 2 May 2023 under Listing Rule 9.4.2R
                                                                  over ordinary shares in Genus.

 c.                    Price(s) and volume(s)

Price  Volume
                                                                  0p     44,933

 
 d.                    Aggregated information                     Price(s)  Volume(s)

                                          0p        44,933
                       ·    Aggregated volume

                       ·    Price

 e.                    Date of the transaction                    2025-02-28
 f.                    Place of the transaction                   Outside a trading venue.
 5.                    Details of the transaction(s): section to be repeated for (i) each type of
                       instrument; (ii) each type of transaction; (iii) each date; and (iv) each
                       place where transactions have been conducted
 a.                    Description of the                                                                  Ordinary shares of 10p each

                       Financial instrument, type of instrument

                       Identification code

                                                                                                           GB0002074580
 b.                    Nature of the transaction                  Sale of shares arising from the exercise of nil-cost options under Listing
                                                                  Rule 9.4.2R to offset income tax and social security liabilities due on the
                                                                  exercise.
 c.                    Price(s) and volume(s)

Price      Volume
                                                                  1,730.51p  19,967

 
 d.                    Aggregated information

Price      Volume
                       ·    Aggregated volume                     1,730.51p  19,967

                       ·    Price

 e.                    Date of the transaction                    2025-02-28
 f.                    Place of the transaction                   London Stock Exchange, Main Market (XLON)

 

d.

Aggregated information

·    Aggregated volume

·    Price

 

 Price(s)  Volume(s)
 0p        44,933

e.

Date of the transaction

2025-02-28

f.

Place of the transaction

Outside a trading venue.

5.

Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Sale of shares arising from the exercise of nil-cost options under Listing
Rule 9.4.2R to offset income tax and social security liabilities due on the
exercise.

c.

Price(s) and volume(s)

 

 Price      Volume
 1,730.51p  19,967

 

d.

Aggregated information

·    Aggregated volume

·    Price

 

 

 Price      Volume
 1,730.51p  19,967

e.

Date of the transaction

2025-02-28

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHUWUORVBUUUAR